Integra Lifesciences down on annual revenue forecast cut

Integra LifeSciences Holdings

25/10/2023 15:39

** Shares of medical equipment maker Integra Lifesciences
Holdings Corp  IART.O  down 5.1% at $35.31
    ** For FY 2023, co cuts revenue expectation to $1.541
bln-$1.547 bln from $1.548 bln-$1.560 bln
    ** Revenue range of annual outlook represents negative
growth of 1.1% to 0.7%, reflecting the impact of higher
than-expected Boston recall returns, co says
    ** IART reports qtrly adjusted EPS $0.76 for Q3 ended Sept.
30, while analysts expected a profit of $0.78
    ** Co reports qtrly total revenue of $382.4 bln vs LSEG
estimate of $387.1 mln
    ** As of last close, IART was down 33.7% YTD

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com))